Semra Paydaş

Çukurova University - Adana / Türkiye

Medical and Health Sciences / Internal Medicine

AD Scientific Index ID: 85387

Çukurova Üniversitesi

Go Premium -
Unlock Full Profile Tools

Get Your Global Impact Certificate

Çukurova University

Semra Paydaş's MOST POPULAR ARTICLES

1-) Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised … The Lancet 397 (10274), 592-604, 2021

2-) Granulocytic sarcoma: 32 cases and review of the literature Leukemia & lymphoma 47 (12), 2527-2541, 2006

3-) Bone marrow necrosis: clinicopathologic analysis of 20 cases and review of the literature American journal of hematology 70 (4), 300-305, 2002

4-) Management of adverse effects/toxicity of ibrutinib Critical Reviews in Oncology/Hematology 136, 56-63, 2019

5-) Efficacy of pneumatic compression and low-level laser therapy in the treatment of postmastectomy lymphoedema: a randomized controlled trial Clinical rehabilitation 23 (2), 117-124, 2009

ARTICLES

Add your articles